NLGN4X up-regulation reduced tumour cell growth in a human organoid model indicating its potential role as a tumour suppressor. Hence, low expression of NLGN4X marks late stage melanoma and experimental protocols leading to up-regulation of NLGN4X might represent promising therapeutic options for melanoma patients. Here, NLGN4X is linked to neoplasm.